NRXN2 Possesses a Tumor Suppressor Potential via Inhibiting the Growth of Thyroid Cancer Cells
Thyroid cancer (THCA) is a common endocrine malignant tumor, and its global incidence of THCA has increased significantly. Neurexin 2 (NRXN2) is involved in the progression of some diseases. Nevertheless, it is still elusive towards the clinical implication and function of NRXN2 in THCA. As The Canc...
Guardado en:
Autores principales: | Cui Ma, Youyou Zhang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8c44192df28840d2ae2c91395e2fcc7b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Meta-Analysis of Contrast Enhanced Ultrasound in Judging Benign and Malignant Thyroid Tumors
por: Qing Wan, et al.
Publicado: (2021) -
Inhibition of miR-15a-5p Promotes the Chemoresistance to Pirarubicin in Hepatocellular Carcinoma via Targeting eIF4E
por: Ying Zhang, et al.
Publicado: (2021) -
miR-19a-3p Promotes Tumor-Relevant Behaviors in Bladder Urothelial Carcinoma via Targeting THBS1
por: Gang Xu, et al.
Publicado: (2021) -
Medical Image Diagnostic Value of Computed Tomography for Bladder Tumors
por: Lin Li, et al.
Publicado: (2021) -
Rapid crowdsourced innovation for COVID-19 response and economic growth
por: Khalil B. Ramadi, et al.
Publicado: (2021)